NO170938C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer

Info

Publication number
NO170938C
NO170938C NO870577A NO870577A NO170938C NO 170938 C NO170938 C NO 170938C NO 870577 A NO870577 A NO 870577A NO 870577 A NO870577 A NO 870577A NO 170938 C NO170938 C NO 170938C
Authority
NO
Norway
Prior art keywords
alkyl
amino
acids
phosphonosubstituted
aminoalky
Prior art date
Application number
NO870577A
Other languages
English (en)
Norwegian (no)
Other versions
NO870577D0 (no
NO870577L (no
NO170938B (no
Inventor
Christof Angst
Derek Edward Brundisch
John Grey Dingwall
Graham Eric Fagg
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO870577D0 publication Critical patent/NO870577D0/no
Publication of NO870577L publication Critical patent/NO870577L/no
Publication of NO170938B publication Critical patent/NO170938B/no
Publication of NO170938C publication Critical patent/NO170938C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826—Acyclic unsaturated acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO870577A 1986-02-13 1987-02-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer NO170938C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH57886 1986-02-13

Publications (4)

Publication Number Publication Date
NO870577D0 NO870577D0 (no) 1987-02-13
NO870577L NO870577L (no) 1987-08-14
NO170938B NO170938B (no) 1992-09-21
NO170938C true NO170938C (no) 1992-12-30

Family

ID=4190244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870577A NO170938C (no) 1986-02-13 1987-02-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme fosfonosubstituerte aminoalkensyrer

Country Status (23)

Country Link
EP (1) EP0233154B1 (es)
JP (2) JPH0717665B2 (es)
KR (1) KR900003533B1 (es)
AT (1) ATE70535T1 (es)
AU (1) AU610493B2 (es)
CA (1) CA1331625C (es)
CY (1) CY1821A (es)
DD (1) DD263775A5 (es)
DE (1) DE3775229D1 (es)
DK (1) DK169341B1 (es)
ES (1) ES2038690T3 (es)
FI (1) FI85144C (es)
GR (1) GR3003526T3 (es)
HK (1) HK95594A (es)
HU (1) HU204532B (es)
IE (1) IE59417B1 (es)
IL (1) IL81543A0 (es)
NO (1) NO170938C (es)
NZ (1) NZ219255A (es)
PH (1) PH23762A (es)
PT (1) PT84270B (es)
SG (1) SG92294G (es)
ZA (1) ZA871022B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
EP0263502A3 (de) * 1986-10-09 1990-05-02 Ciba-Geigy Ag Oligopeptid-Antibiotika
EP0302826A3 (de) * 1987-08-04 1991-04-03 Ciba-Geigy Ag Verfahren zur Herstellung neuer ungesättigter Aminosäureverbindungen
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
US5179085A (en) * 1989-03-15 1993-01-12 Warner-Lambert Company N-substituted α-amino acids and derivatives thereof having pharmaceutical activity
ES2060122T3 (es) * 1989-04-07 1994-11-16 Ciba Geigy Ag Derivados insaturados de acidos aminodicarboxilicos.
US5500419A (en) * 1989-09-19 1996-03-19 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
DE59009368D1 (de) * 1989-09-26 1995-08-10 Ciba Geigy Ag Phosphonsäure, Verfahren zur Herstellung und Verwendung als Arzneimittelwirkstoff.
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア ルイザ Nmda受容体のアロステリックモジュレーター
US20090170813A1 (en) * 2005-10-18 2009-07-02 Francine Acher Hypophosphorous Acid Derivatives and their Therapeutical Applications
DE102007032669A1 (de) 2007-07-13 2009-01-15 Clariant International Limited Alkylphosphonigsäuren, -salze und -ester, Verfahren zu deren Herstellung und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477391A (en) * 1981-08-14 1984-10-16 Collins James F Amino acid isomers, their production and their medicinal use
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use

Also Published As

Publication number Publication date
PH23762A (en) 1989-11-03
FI85144C (fi) 1992-03-10
FI85144B (fi) 1991-11-29
IE59417B1 (en) 1994-02-23
ES2038690T3 (es) 1993-08-01
AU6872687A (en) 1987-08-20
CA1331625C (en) 1994-08-23
PT84270A (en) 1987-03-01
ZA871022B (en) 1987-09-30
JPS62246586A (ja) 1987-10-27
FI870558A7 (fi) 1987-08-14
JP2509465B2 (ja) 1996-06-19
HK95594A (en) 1994-09-16
SG92294G (en) 1995-04-28
EP0233154A2 (de) 1987-08-19
NO870577D0 (no) 1987-02-13
NZ219255A (en) 1989-08-29
KR870007942A (ko) 1987-09-23
PT84270B (pt) 1989-09-14
JPH0717665B2 (ja) 1995-03-01
HU204532B (en) 1992-01-28
IE870365L (en) 1987-08-13
DD263775A5 (de) 1989-01-11
NO870577L (no) 1987-08-14
ATE70535T1 (de) 1992-01-15
GR3003526T3 (es) 1993-03-16
EP0233154A3 (en) 1989-06-14
DK169341B1 (da) 1994-10-10
KR900003533B1 (ko) 1990-05-21
DE3775229D1 (de) 1992-01-30
JPH07206683A (ja) 1995-08-08
HUT43863A (en) 1987-12-28
DK70787D0 (da) 1987-02-12
IL81543A0 (en) 1987-09-16
AU610493B2 (en) 1991-05-23
EP0233154B1 (de) 1991-12-18
CY1821A (en) 1995-10-20
FI870558A0 (fi) 1987-02-11
NO170938B (no) 1992-09-21
DK70787A (da) 1987-08-14

Similar Documents

Publication Publication Date Title
ATE70535T1 (de) Ungesaettigte aminosaeuren.
AR034556A1 (es) Un derivado de fenilalanina, una composicion farmaceutica que comprende al derivado de fenilalanina, el uso del derivado y proceso para preparar dicho derivado
NO932614L (no) Heteroeddiksyrederivater
DE69633398D1 (de) Betulinsäure-derivate und ihre verwendungen
HUP9701540A1 (hu) A gasztrointesztinális keringést elősegítő gyógyászati készítmény
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
ES8606394A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES2058173T3 (es) Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK0552060T3 (da) Imidazolderivater med anti-HIV-virkning
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
DE3787796D1 (de) Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln.
ATE32715T1 (de) Verfahren zur herstellung von b-((2methylpropoxy)-methyl>-n-phenyl-n-(phenylmethyl - 1-pyrrolidinethanamin.
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
GB1369577A (en) Indole-carboxylic acid derivatives
ATE62684T1 (de) Hydroxyindolester.
FI870057A0 (fi) Nya tyroninderivat.
ES8602815A1 (es) Un derivado de cefalosporina
FR2244489A1 (en) 3-Halo-4-heterocyclic substd.-phenylalkanoic acids - their esters and salts with antiinflammatory activity
SE8204641L (sv) Aminosyraderivat
FR2043463A1 (en) Benzoxazines and benzothiazines having c n s and
SU681818A1 (ru) Эфиры α-триалкилсилоксикарбоновых кислот, проявляющие анальгетическую или пролонгирующую гексеналовый наркоз активность
ES2095831T3 (es) Acidos tetrahidro-4-fenilimino-3-tiofeno-aceticos.
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
PT80187A (en) A process for the preparation of quinoline carboxylic acid derivatives